Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Esperion Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Esperion Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hoffman Robert | Director | 0 | Jul 13, 2026 | 2 |
| Carroll J Martin | Director | 0 | Jul 13, 2026 | 2 |
| Shepard Jay | Director | 0 | Jul 13, 2026 | 2 |
| Fischer Seth H. Z. | Director | 0 | Jul 13, 2026 | 2 |
| Thompson John Craig | Director | 0 | Jul 13, 2026 | 2 |
| Harlow John B. Jr. | Chief Commercial Officer | 0 | Jul 13, 2026 | 2 |
| Looker Benjamin | Chief Legal Officer | 0 | Jul 13, 2026 | 7 |
| Halladay Benjamin | Chief Financial Officer | 0 | Jul 13, 2026 | 5 |
| Koenig Sheldon L. | President and CEO | 0 | Jul 13, 2026 | 5 |
| Vitullo Nicole | Director | 36,918 | Jun 2, 2025 | 0 |
| Rocamboli Stephen | Director | 69,261 | Jun 2, 2025 | 0 |
| Woody Tracy M | Director | 33,566 | Jun 2, 2025 | 0 |
| Warren Eric | Chief Commercial Officer | 370,218 | Apr 21, 2025 | 0 |
| Foody Joanne M. | Chief Medical Officer | 272,862 | Jul 19, 2024 | 0 |
| Gotto Antonio M Jr MD D Phil | Director | 51,599 | May 24, 2024 | 0 |
| Fuhrman Alan | Director | 53,404 | May 24, 2024 | 0 |
| Berkowitz Jeffrey | Director | – | May 27, 2022 | 0 |
| Bartram Richard | Chief Financial Officer | 82,751 | Mar 16, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 (view filing) | Apr 19 | 1 day | Looker BenjaminGeneral Counsel | SSale | −1.29K | $1.27 | −$1.64K | −1.5%83.7K after | |
| Apr 20, 2023 (view filing) | Apr 19 | 1 day | Foody Joanne M.Chief Medical Officer | SSale | −938 | $1.27 | −$1.19K | −0.7%127.1K after | |
| Mar 20, 2023 (view filing) | Mar 17 | 3 days | Foody Joanne M.Chief Medical Officer | SSale | −3.81K | $1.78 | −$6.78K | −2.9%128.0K after | |
| Mar 20, 2023 (view filing) | Mar 17 | 3 days | Koenig Sheldon L.President and CEO | SSale | −7.00K | $1.78 | −$12.5K | −2.3%292.8K after | |
| Mar 20, 2023 (view filing) | Mar 17 | 3 days | Warren EricChief Commercial Officer | SSale | −526 | $1.78 | −$936.28 | −0.7%70.3K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Warren EricChief Commercial Officer | SSale | −5.09K | $5.06 | −$25.8K | −9.5%48.6K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Koenig Sheldon L.President and CEO | SSale | −5.44K | $5.06 | −$27.5K | −2.7%194.8K after | |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Foody Joanne M.Chief Medical Officer | SSale | −3.88K | $5.07 | −$19.7K | −3.6%103.1K after | |
| Jan 19, 2023 (view filing) | Jan 18 | 1 day | Looker BenjaminGeneral Counsel | SSale | −6.35K | $7.00 | −$44.4K | −9.0%64.5K after | |
| Jan 19, 2023 (view filing) | Jan 18 | 1 day | Foody Joanne M.Chief Medical Officer | SSale | −1.19K | $6.99 | −$8.33K | −1.1%106.9K after | |
| Oct 19, 2022 (view filing) | Oct 18 | 1 day | Foody Joanne M.Chief Medical Officer | SSale | −942 | $7.69 | −$7.24K | −0.9%108.1K after | |
| Oct 19, 2022 (view filing) | Oct 18 | 1 day | Warren EricChief Commercial Officer | SSale | −107 | $7.69 | −$822.83 | −0.2%53.7K after | |
| Sep 20, 2022 (view filing) | Sep 19 | 1 day | Warren EricChief Commercial Officer | SSale | −255 | $6.92 | −$1.76K | −0.5%53.8K after | |
| Sep 20, 2022 (view filing) | Sep 19 | 1 day | Koenig Sheldon L.President and CEO | SSale | −3.39K | $6.94 | −$23.6K | −1.7%198.3K after | |
| Aug 31, 2022 (view filing) | Aug 31 | Same day | Warren EricChief Commercial Officer | PPurchase | +1.00K | $7.46 | +$7.46K | +1.9%54.0K after | |
| Aug 18, 2022 (view filing) | Aug 17 | 1 day | Warren EricChief Commercial Officer | SSale | −199 | $6.82 | −$1.36K | −0.4%53.0K after | |
| Aug 8, 2022 (view filing) | Aug 5 | 3 days | Koenig Sheldon L.President and CEO | PPurchase | +8.61K | $5.80 | +$49.9K | +4.5%198.8K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Foody Joanne M.Chief Medical Officer | SSale | −3.90K | $6.55 | −$25.6K | −3.5%109.1K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Warren EricChief Commercial Officer | SSale | −431 | $6.58 | −$2.84K | −0.8%53.2K after | |
| Jun 21, 2022 (view filing) | Jun 17 | 4 days | Koenig Sheldon L.President and CEO | SSale | −4.55K | $4.99 | −$22.7K | −2.3%190.2K after | |
| Jun 21, 2022 (view filing) | Jun 17 | 4 days | Warren EricChief Commercial Officer | SSale | −256 | $4.90 | −$1.25K | −0.5%53.7K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Carroll J MartinDirector | PPurchase | +5.00K | $5.64 | +$28.2K | New position5.00K after | |
| May 18, 2022 (view filing) | May 17 | 1 day | Warren EricChief Commercial Officer | SSale | −196 | $5.98 | −$1.17K | −0.4%53.9K after | |
| Mar 18, 2022 (view filing) | Mar 17 | 1 day | Koenig Sheldon L.President and CEO | SSale | −571 | $4.58 | −$2.62K | −0.3%194.7K after |